Sorrento’s vaccine shows promise against coronavirus, variants in animal studies Reuters Aug 20, 2021 The sera of vaccinated mice showed neutralisation of infection caused by the original coronavirus and major variants of concern…
Sorrento gets US FDA nod for Phase 1 clinical trial of neutralising antibody in COVID-19 patients EP News Bureau Sep 17, 2020 Sorrento had earlier informed that COVI-GUARD (STI-1499) demonstrated 100 per cent in vitro neutralizing effect against SARS-CoV-2…
Cancer CART therapy: What are the benefits and stakes? EP News Bureau Jun 13, 2020 Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how…
